COVID-19 Pandemic Alters Epidemiology of Acute Respiratory Infections in Children in Wuhan, China

A recent study published in The Journal of Infection in Developing Countries has revealed the impact of the COVID-19 pandemic on the detection rate of common pathogens causing acute respiratory infections (ARI) in children aged 6 years or younger in Wuhan, China. The research, conducted by a team of scientists from Renmin Hospital of Wuhan University, analyzed 12,743 throat swab specimens collected from hospitalized children with ARI symptoms between March 2019 and January 2023. The study found that the detection rates of respiratory pathogens were significantly lower than average during the COVID-19 pandemic.

Key Takeaways:

  • The study analyzed 12,743 throat swab specimens collected from hospitalized children with ARI symptoms in Wuhan, China between March 2019 and January 2023.
  • Human rhinoviruses (HRV) had the highest detection rate (2,475 cases, 19.42%), with a prevalence mainly in spring and autumn.
  • Respiratory syncytial virus (RSV) was mainly popular in fall and winter.
  • The detection rates of respiratory pathogens were significantly lower than average during the COVID-19 pandemic (p < 0.05).
  • The study found that the COVID-19 pandemic had altered the epidemiology of ARI in children aged 6 years or younger in Wuhan, China.
  • Of the 12,743 samples collected, 6,200 cases (48.65%) were positive for at least one pathogen.
  • The study's findings highlight the importance of monitoring the epidemiology of respiratory pathogens during pandemics to inform public health policies and interventions.

Statistics:

  • 12,743 throat swab specimens were collected from hospitalized children with ARI symptoms.
  • 6,200 cases (48.65%) were positive for at least one pathogen.
  • Human rhinoviruses (HRV) had a detection rate of 2,475 cases (19.42%).
  • Respiratory syncytial virus (RSV) was detected in 1,234 cases (9.7%).
  • The detection rates of respiratory pathogens were significantly lower than average during the COVID-19 pandemic (p < 0.05).

Sources:

  • The Journal of Infection in Developing Countries, 2025; 19(06):825-832.